Status:

UNKNOWN

VOLTage Mapping in Atrial Fibrillation

Lead Sponsor:

Central Hospital, Nancy, France

Conditions:

Atrial Fibrillation, Persistent

Eligibility:

All Genders

Brief Summary

The purpose of this study is to retrospectively analyze electroanatomical data collected during persistent atrial fibrillation ablation procedures, combined with pre-ablation cardiac CT data, in order...

Detailed Description

Background: Atrial fibrillation (AF) is the most common arrhythmia, with an estimated prevalence in 2010 of 33.5 million people (3% of the world population). It is now estimated that 1 in 4 middle-ag...

Eligibility Criteria

Inclusion

  • Persistant Atrial fibrillation ablation
  • Voltage map in sinus rhythm and in atrial fibrillation
  • Cardiac CT scan performed before ablation

Exclusion

  • Incomplete data, poor quality ECG recordings.

Key Trial Info

Start Date :

April 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2022

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04832646

Start Date

April 1 2021

End Date

April 1 2022

Last Update

April 6 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital of Nancy

Vandœuvre-lès-Nancy, France, 54500

VOLTage Mapping in Atrial Fibrillation | DecenTrialz